Samsung Bioepis - Crunchbase Company Profile & Funding

Q: Who invested in Samsung Bioepis?

Samsung Bioepis is funded by Biogen.

Q: When was the last funding round for Samsung Bioepis?

Samsung Bioepis closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Samsung Bioepis raised to date?

Samsung Bioepis has raised obfuscated.

Overview

Samsung Bioepis

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Samsung Bioepis

CB Rank

3048

Samsung Bioepis is a biopharmaceutical company.

Acquired by

Samsung BioLogics

Founded

obfuscation

Private

Venture - Series Unknown

Incheon, Inch'on-jikhalsi, South Korea

501-1000

www.samsungbioepis.com

Biotechnology

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Kyung-Ah Kim: EVP
Past Role: Samsung Advanced Institute of Technology, Vice President
Ho Sung Cho: Executive Vice President
Past Role: Celgene, Vice President, Biotherapeutics

Details

Legal Name

Samsung Bioepis Co., Ltd.

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

About the Company

Samsung Bioepis Co., Ltd. develops and produces biopharmaceutical and biosimilar products. Samsung Bioepis Co., Ltd. has a strategic collaboration agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2012 and is based in Incheon,

Phone Number

+82 - 32 - 455 - 6114

Contact Email

office.ceohq@gmail.com

Predictions & Insights

Growth Insight

See this Growth Insight

Samsung Bioepis is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

IMRALDI™ (adalimumab)

A biosimilar to adalimumab used to treat autoimmune diseases such as rheumatoid arthritis and Crohn’s disease.

BRENZYS™ (etanercept)

A biosimilar to etanercept for treating autoimmune diseases like rheumatoid arthritis and psoriasis.

Research & Development

Samsung Bioepis is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Samsung Bioepis	1	obfuscated obfuscation	Biogen	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Biogen	Yes	Venture Round - Samsung Bioepis	—
Biogen	Yes	Venture Round - Samsung Bioepis	—
Biogen	Yes	Venture Round - Samsung Bioepis	—
Biogen	Yes	Venture Round - Samsung Bioepis	—
Biogen	Yes	Venture Round - Samsung Bioepis	—

Investments

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation
obfuscated obfuscation	G2GBIO	—	Post-IPO Debt - G2GBIO	obfuscated obfuscation